Migrastatics—Anti-metastatic and Anti-invasion Drugs: Promises and Challenges

In solid cancers, invasion and metastasis account for more than 90% of mortality. However, in the current armory of anticancer therapies, a specific category of anti-invasion and antimetastatic drugs is missing. Here, we coin the term ‘migrastatics’ for drugs interfering with all modes of cancer cel...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Trends Cancer
Egile Nagusiak: Gandalovičová, Aneta, Rosel, Daniel, Fernandes, Michael, Veselý, Pavel, Heneberg, Petr, Čermák, Vladimír, Petruželka, Luboš, Kumar, Sunil, Sanz-Moreno, Victoria, Brábek, Jan
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Cell Press 2017
Gaiak:
Opinion
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5482322/
https://ncbi.nlm.nih.gov/pubmed/28670628
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trecan.2017.04.008
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak